IMT030122

N/A

Report date: 2026/03/19 17:14:43

Base Information

Drug NameIMT030122
Drug Alias NameIMT030122IMT-030122
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsAnti-EpCAMAnti-CD3
TargetsTumor necrosis factor receptor superfamily member 9Epithelial cell adhesion moleculeT cell surface glycoprotein CD3
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijng Immunoah Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijng Immunoah Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A